haloperidol has been researched along with Ventricular Fibrillation in 6 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ventricular fibrillation has been observed in association with the administration of haloperidol." | 7.68 | The effect of haloperidol on ventricular fibrillation threshold in pigs. ( Chow, MS; Kambe, JC; Tisdale, JE; Yeston, NS, 1991) |
| " Because dopaminergic receptor agonists reduce sympathetic outflow, this study assessed effectiveness of the available dopaminergic agonist, bromocriptine, in slowing or terminating ouabain-induced ventricular tachycardia in anesthetized dogs." | 7.67 | Bromocriptine treatment of digitalis-induced ventricular tachyarrhythmias: studies in a canine model. ( Benditt, DG; Benson, DW; Detloff, BL; Kao, A; Kriett, JM; Pritzker, MR; Tobler, HG, 1984) |
| "The effect of a dopamine agonist, bromocriptine, on ventricular fibrillation (VF) threshold was studied in anaesthetised dogs." | 7.66 | Reduction in vulnerability to ventricular fibrillation by bromocriptine, a dopamine agonist. ( Desilva, RD; Falk, RH; Lown, B, 1981) |
| " He had a history of schizophrenia that had been controlled with propericiazine 10 mg and bromperidol 3 mg daily for 34 years." | 3.78 | [Severe hypotension and ventricular fibrillation during combined general and epidural anesthesia in a patient on major tranquilizers]. ( Abe, R; Fujita, K; Futsukaichi, K; Matsumoto, K; Noguchi, T, 2012) |
| " Because dopaminergic receptor agonists reduce sympathetic outflow, this study assessed effectiveness of the available dopaminergic agonist, bromocriptine, in slowing or terminating ouabain-induced ventricular tachycardia in anesthetized dogs." | 3.67 | Bromocriptine treatment of digitalis-induced ventricular tachyarrhythmias: studies in a canine model. ( Benditt, DG; Benson, DW; Detloff, BL; Kao, A; Kriett, JM; Pritzker, MR; Tobler, HG, 1984) |
| "The effect of a dopamine agonist, bromocriptine, on ventricular fibrillation (VF) threshold was studied in anaesthetised dogs." | 3.66 | Reduction in vulnerability to ventricular fibrillation by bromocriptine, a dopamine agonist. ( Desilva, RD; Falk, RH; Lown, B, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kryzhanovskyi, SA | 1 |
| Stolyaruck, VN | 1 |
| Vititnova, MB | 1 |
| Tsorin, IB | 1 |
| Seredenin, SB | 1 |
| Futsukaichi, K | 1 |
| Matsumoto, K | 1 |
| Fujita, K | 1 |
| Abe, R | 1 |
| Noguchi, T | 1 |
| Gomez, J | 1 |
| Scott, G | 1 |
| Kao, A | 1 |
| Kriett, JM | 1 |
| Tobler, HG | 1 |
| Detloff, BL | 1 |
| Pritzker, MR | 1 |
| Benson, DW | 1 |
| Benditt, DG | 1 |
| Falk, RH | 1 |
| Desilva, RD | 1 |
| Lown, B | 1 |
| Tisdale, JE | 1 |
| Kambe, JC | 1 |
| Chow, MS | 1 |
| Yeston, NS | 1 |
6 other studies available for haloperidol and Ventricular Fibrillation
| Article | Year |
|---|---|
On the mechanism of antifibrillatory effect of afobazole.
Topics: Animals; Anti-Arrhythmia Agents; Benzimidazoles; Haloperidol; Heart; Male; Morpholines; Myocytes, Ca | 2010 |
[Severe hypotension and ventricular fibrillation during combined general and epidural anesthesia in a patient on major tranquilizers].
Topics: Anesthesia, Epidural; Anesthesia, General; Antipsychotic Agents; Haloperidol; Humans; Hypotension; I | 2012 |
Hypothyroidism, psychotropic drugs and cardiotoxicity.
Topics: Acute Disease; Adult; Antipsychotic Agents; Female; Haloperidol; Humans; Hypothyroidism; Phenothiazi | 1980 |
Bromocriptine treatment of digitalis-induced ventricular tachyarrhythmias: studies in a canine model.
Topics: Animals; Blood Pressure; Bromocriptine; Dogs; Domperidone; Female; Haloperidol; Male; Ouabain; Preme | 1984 |
Reduction in vulnerability to ventricular fibrillation by bromocriptine, a dopamine agonist.
Topics: Animals; Benzimidazoles; Bromocriptine; Dogs; Domperidone; Dopamine Antagonists; Female; Haloperidol | 1981 |
The effect of haloperidol on ventricular fibrillation threshold in pigs.
Topics: Animals; Electrocardiography; Haloperidol; Hemodynamics; Infusions, Intravenous; Sensory Thresholds; | 1991 |